230 related articles for article (PubMed ID: 30828802)
1. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
Barcellini W; Zaninoni A; Gregorini AI; Soverini G; Duca L; Fattizzo B; Giannotta JA; Pedrotti P; Vercellati C; Marcello AP; Fermo E; Bianchi P; Cappellini MD
Br J Haematol; 2019 May; 185(3):523-531. PubMed ID: 30828802
[TBL] [Abstract][Full Text] [Related]
2. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
3. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
5. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
Brunacci F; Rocha VS; De Carli E; EspĆ³sito BP; Ruano R; Colli C
Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
[TBL] [Abstract][Full Text] [Related]
6. Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.
Porter JB; El-Alfy M; Viprakasit V; Giraudier S; Chan LL; Lai Y; El-Ali A; Han J; Cappellini MD
Eur J Haematol; 2016 Jan; 96(1):19-26. PubMed ID: 25691036
[TBL] [Abstract][Full Text] [Related]
7. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
8. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
10. Congenital Hemolytic Anemias: Is There a Role for the Immune System?
Zaninoni A; Fermo E; Vercellati C; Marcello AP; Barcellini W; Bianchi P
Front Immunol; 2020; 11():1309. PubMed ID: 32655575
[TBL] [Abstract][Full Text] [Related]
11. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
12. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
13. Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin.
Bilar JM; Fucuta PDS; Feldner AC; Caravalho Filho R; Silva I; Pestana JM; Ferraz ML
Transplant Proc; 2020; 52(1):169-174. PubMed ID: 31955851
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin levels in children with chronic liver disease.
Cakir M; Erduran E; Turkmen ES; Aliyazicioglu Y; Reis GP; Cobanoglu U; Demir S
Saudi J Gastroenterol; 2015; 21(5):300-5. PubMed ID: 26458857
[TBL] [Abstract][Full Text] [Related]
15. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
McNamara L; MacPhail AP; Mandishona E; Bloom P; Paterson AC; Rouault TA; Gordeuk VR
J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
[TBL] [Abstract][Full Text] [Related]
17. Iron Parameters Determine the Prognosis of Critically Ill Patients.
Tacke F; Nuraldeen R; Koch A; Strathmann K; Hutschenreuter G; Trautwein C; Strnad P
Crit Care Med; 2016 Jun; 44(6):1049-58. PubMed ID: 26934143
[TBL] [Abstract][Full Text] [Related]
18. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
[TBL] [Abstract][Full Text] [Related]
20. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]